000 | 02916nam a22004335i 4500 | ||
---|---|---|---|
001 | 978-3-642-28965-1 | ||
003 | DE-He213 | ||
005 | 20140220083314.0 | ||
007 | cr nn 008mamaa | ||
008 | 120626s2012 gw | s |||| 0|eng d | ||
020 |
_a9783642289651 _9978-3-642-28965-1 |
||
024 | 7 |
_a10.1007/978-3-642-28965-1 _2doi |
|
050 | 4 | _aQD1-999 | |
072 | 7 |
_aPN _2bicssc |
|
072 | 7 |
_aSCI013000 _2bisacsh |
|
072 | 7 |
_aTEC012000 _2bisacsh |
|
082 | 0 | 4 |
_a540 _223 |
100 | 1 |
_aWendt, Michael D. _eeditor. |
|
245 | 1 | 0 |
_aProtein-Protein Interactions _h[electronic resource] / _cedited by Michael D. Wendt. |
264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2012. |
|
300 |
_aXVIII, 261 p. 175 illus., 39 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aTopics in Medicinal Chemistry, _x1862-2461 ; _v8 |
|
505 | 0 | _aProtein-Protein Interactions as Drug Targets -- Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics -- The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer -- Protein-Protein Interaction Targets to Inhibit HIV-1 Infection -- Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus -- Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces -- The Discovery of Navitoclax, a Bcl-2 Family Inhibitor. | |
520 | _aMichael D. Wendt Protein-Protein Interactions as Drug Targets Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj Vucic The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto Protein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. Langley Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. Wendt The Discovery of Navitoclax, a Bcl-2 Family Inhibitor | ||
650 | 0 | _aChemistry. | |
650 | 1 | 4 | _aChemistry. |
650 | 2 | 4 | _aChemistry/Food Science, general. |
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9783642289644 |
830 | 0 |
_aTopics in Medicinal Chemistry, _x1862-2461 ; _v8 |
|
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-642-28965-1 |
912 | _aZDB-2-CMS | ||
999 |
_c102930 _d102930 |